EU Trails US FDA In Device Cybersecurity Guidance, But Harmonization Anticipated
This article was originally published in SRA
The US Food and Drug Administration appears to be ahead of the EU in efforts to issue guidelines specific to medical device cybersecurity. But experts say regulators in the EU are likely to eventually harmonize as part of a global effort to address cybersecurity risks.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.